Positive and Negative Aspects of Copaxone ( Glatiramer Acetate) Action on TC, TG HbA1cand IronLevels in the Sera of Iraqi Women With Multiple Sclerosis in Baghdad

Baghdad Science Journal - Iraq
doi 10.21123/bsj.2017.14.1.0157
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

College of Science for Women

Related search

Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2011English

Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis

Journal of Central Nervous System Disease
2012English

Promoting Oligodendrogenesis and Myelin Repair Using the Multiple Sclerosis Medication Glatiramer Acetate

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated With Interferon Beta or Glatiramer Acetate

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Examining the Influence of Behavioral Factors on Compliance and Persistence With Glatiramer Acetate Injection for Relapsing-Remitting Multiple Sclerosis

Journal of Neurology & Neurophysiology
2014English

Pnd12 - Natalizumab Versus Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pnd34 - Payer and Societal Benefit of Peginterferon Beta-1a Versus Glatiramer Acetate in Patients With Relapsing-Remitting Multiple Sclerosis in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pnd33 - Payer and Societal Benefit of Peginterferon Beta-1a Versus Glatiramer Acetate in Patients With Relapsing-Remitting Multiple Sclerosis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy